Physician
Oncology
Dr. Patricia Cortazar, MD
|
|
Give Review
Patricia Cortazar is an expert in the field of Oncology. Dr. Patricia Cortazar is a published doctor and has 11 publications published. The lastest was: 'Survival of patients with limited-stage small cell lung cancer treated with individualized chemotherapy selected by in vitro drug sensitivity testing.'
Publications
- FDA Approval: Palbociclib for the Treatment of Postmenopausal Patients with Estrogen Receptor-Positive, HER2-Negative Metastatic Breast Cancer.
- Pathological Complete Response in Neoadjuvant Treatment of Breast Cancer.
- First FDA Approval of Neoadjuvant Therapy for Breast Cancer: Pertuzumab for the Treatment of Patients with HER2-Positive Breast Cancer.
- American Society of Clinical Oncology Perspective: Raising the Bar for Clinical Trials by Defining Clinically Meaningful Outcomes.
- First FDA Approval of Dual Anti-HER2 Regimen: Pertuzumab in Combination with Trastuzumab and Docetaxel for HER2-Positive Metastatic Breast Cancer.
- US Food and Drug Administration approval overview in metastatic breast cancer.
- Approval summary: pemetrexed maintenance therapy of advanced/metastatic nonsquamous, non-small cell lung cancer (NSCLC).
- Approval summary: imatinib mesylate in the adjuvant treatment of malignant gastrointestinal stromal tumors.
- Second lung cancers in patients successfully treated for lung cancer.
- Survival of patients with limited-stage small cell lung cancer treated with individualized chemotherapy selected by in vitro drug sensitivity testing.
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Helpful Reviews
Similar Doctors
|
|
Dr. Eva Szabo, MD |
|
|
Dr. Elise C. Kohn, MD |
|
|
Dr. Elisabeth B. Simms, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gabriel P. Pushkas, MD |